BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6245704)

  • 21. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
    de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
    J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural features of the first component of human complement, C1, as revealed by surface iodination.
    Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
    Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C1r serine proteinase of human complement: a case of intramolecular autolytic activation.
    Arlaud GJ; Colomb MG; Villiers CL
    Biosci Rep; 1985; 5(10-11):831-7. PubMed ID: 3006820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of Cl, the first component of complement, the generation of Clr-Cls and Cl- inactivator complexes in normal serum by heparin-affinity chromatography.
    McKay EJ; Laurell AB; Mårtensson U; Sjöholm AG
    Mol Immunol; 1981 May; 18(5):349-57. PubMed ID: 6273714
    [No Abstract]   [Full Text] [Related]  

  • 27. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19.
    Thiel S; Petersen SV; Vorup-Jensen T; Matsushita M; Fujita T; Stover CM; Schwaeble WJ; Jensenius JC
    J Immunol; 2000 Jul; 165(2):878-87. PubMed ID: 10878362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biochemical data on C1 intrinsic activation (author's transl)].
    Colomb MG; Bensa JC; Villiers CL; Arlaud GJ
    Ann Immunol (Paris); 1982; 133C(2):155-64. PubMed ID: 6287903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant protein A regulates complement activation.
    Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
    J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of interaction of C1 inhibitor with complement C1s.
    Lennick M; Brew SA; Ingham KC
    Biochemistry; 1986 Jul; 25(13):3890-8. PubMed ID: 3091067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
    Jackson J; Sim RB; Whaley K; Feighery C
    J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proenzymic C1s associated with catalytic amounts of C1r. Study of the activation process.
    Arlaud GJ; Reboul A; Colomb MG
    Biochim Biophys Acta; 1977 Nov; 485(1):227-35. PubMed ID: 303116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human complement system serine proteases C1r and C1s and their proenzymes.
    Sim RB
    Methods Enzymol; 1981; 80 Pt C():26-42. PubMed ID: 6281620
    [No Abstract]   [Full Text] [Related]  

  • 34. The reconstitution of human C1, the first complement component: binding of C1r and C1s to C1q influences the C1q conformation.
    Golan MD; Hitschold T; Loos M
    FEBS Lett; 1981 Jun; 128(2):281-5. PubMed ID: 6266874
    [No Abstract]   [Full Text] [Related]  

  • 35. Calcium-sensitive thermal transitions and domain structure of human complement subcomponent C1r.
    Busby TF; Ingham KC
    Biochemistry; 1987 Aug; 26(17):5564-71. PubMed ID: 2823884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary structure of the reactive site of human C1-inhibitor.
    Salvesen GS; Catanese JJ; Kress LF; Travis J
    J Biol Chem; 1985 Feb; 260(4):2432-6. PubMed ID: 3919001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-stimulated modification of C1-inhibitor by subcomponent C1s of human complement.
    Weiss V; Engel J
    Hoppe Seylers Z Physiol Chem; 1983 Mar; 364(3):295-301. PubMed ID: 6602754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of the fluid-phase proteolytic cleavage of human complement subcomponents C4 and C2 by C1s and C1r2-C1s2.
    Thielens NM; Villiers CL; Villiers MB; Colomb MG
    FEBS Lett; 1984 Jan; 165(1):111-6. PubMed ID: 6319179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classical complement pathway components C1r and C1s: purification from human serum and in recombinant form and functional characterization.
    Rossi V; Bally I; Lacroix M; Arlaud GJ; Thielens NM
    Methods Mol Biol; 2014; 1100():43-60. PubMed ID: 24218249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complement.
    Villiers CL; Arlaud GJ; Colomb MG
    Proc Natl Acad Sci U S A; 1985 Jul; 82(13):4477-81. PubMed ID: 2989825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.